---
schema_version: "secwatch.filing_event.v1"
accession: "0000885978-23-000041"
form_type: "8-K"
ticker: "USPH"
cik: "0000885978"
company_name: "U S PHYSICAL THERAPY INC /NV"
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T12:29:06.412385+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# USPH Q3 revenue $150M (+7.5%); adj. EBITDA $18.6M (+9.4%); GAAP EPS $0.51

## Summary
- Total net revenue of $150M, up 7.5% YoY; net patient revenue from PT ops up 9.0% to $127.2M.
- Adjusted EBITDA of $18.6M, up $1.6M from $17.0M in prior-year quarter.
- GAAP net income attributable to USPH of $9.3M ($0.51 diluted EPS) vs $9.6M ($0.72) in Q3 2022.
- Record-high third-quarter patient volume: average 29.7 visits per clinic per day, total visits up 10.8%.
- Quarterly dividend of $0.43 per share declared; full-year Adjusted EBITDA guidance at $75M-$80M.

## SEC filing metadata
- accession: 0000885978-23-000041
- form_type: 8-K
- ticker: USPH
- cik: 0000885978
- company_name: U S PHYSICAL THERAPY INC /NV
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885978/000088597823000041/0000885978-23-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885978/000088597823000041/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885978-23-000041
- JSON: https://secwatch.observer/filing/0000885978-23-000041.json
- Plain text: https://secwatch.observer/filing/0000885978-23-000041.txt

## Key facts
- Earnings Releases
  U S PHYSICAL THERAPY INC /NV updated its three and nine months ended September 30, 2023 guidance (reaffirmed).
  - Period: three and nine months ended September 30, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: reported results for the three and nine months ended September 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885978/000088597823000041/0000885978-23-000041-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.